Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlkemy Capital. Regulatory News (ALK)

Share Price Information for Alkemy Capital. (ALK)

Share Price is delayed by 15 minutes
Get Live Data
218.00    -17.00 (-7.02%)
Bid:
221.00
Ask:
229.00
Spread: 8.00 (3.62%)
Market Cap: £23.93m
ALK Live PriceLast checked at - London Stock Exchange

Intraday Alkemy Capital. Share Chart

Publication of a Prospectus

25 Feb 2022 14:30

RNS Number : 9078C
Alkemy Capital Investments PLC
25 February 2022
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT IS AN ADVERTISEMENT AND IS NOT A PROSPECTUS AND NOT AN OFFER FOR SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR INTO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW. INVESTORS SHOULD NOT PURCHASE OR SUBSCRIBE FOR ANY SHARES REFERRED TO IN THIS ANNOUNCEMENT EXCEPT ON THE BASIS OF INFORMATION IN THE PROSPECTUS (THE "PROSPECTUS") PUBLISHED BY ALKEMY CAPITAL INVESTMENT PLC, IN CONNECTION WITH THE PROPOSED ADMISSION OF ITS ORDINARY SHARES TO THE STANDARD LISTING SEGMENT OF THE OFFICIAL LIST OF THE FINANCIAL CONDUCT AUTHORITY AND TO TRADING ON THE MAIN MARKET FOR LISTED SECURITIES OF LONDON STOCK EXCHANGE PLC (THE "LONDON STOCK EXCHANGE" OR "LSE") (TOGETHER, "ADMISSION"). THE PROSPECTUS IS AVAILABLE ON THE COMPANY'S WEBSITE AT WWW.ALKEMYCAPITAL.CO.UK.

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT IS NOT FOR RELEASE,PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR INTO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW.

 

25 February 2022

 

Alkemy Capital Investments Plc

("Alkemy" or the "Company)

 

Publication of Prospectus

 

Alkemy is pleased to announce that its prospectus (the "Prospectus") in support of its intention to re-list on the London Stock Exchange has been approved by the Financial Conduct Authority and was published today.

 

The Prospectus is being issued in connection with the Company's application for admission of its entire issued share capital, being 5,999,999 ordinary shares or £0.02 each ("Ordinary Shares") to the Standard segment of the Official List and to trading on the London Stock Exchange's Main Market for listed securities ("Re-admission").

 

The Company expects that Re-admission will become effective and that dealings in the Ordinary Shares will commence on 2 March 2022 at 8.00 a.m. (London time) under the ticker symbol: ALK.

 

A copy of the Prospectus will be submitted to the National Storage Mechanism and will shortly be available for inspection (subject to securities laws) at www.data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

The Prospectus is available on the Company's website at www.alkemycapital.co.uk.

 

 

** Ends **

 

For further information, please contact: 

Sam Quinn Director, Alkemy Capital Investments PlcTelephone: 0207 317 0636

Email: info@alkemycapital.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIZZGZZDKFGZZM
Date   Source Headline
28th May 20267:00 amRNSAnnual Report & Financial Statements
24th Apr 20267:00 amRNSTVL Project Development Update
19th Mar 20267:00 amRNSTVL Industry Engagement Update
27th Feb 20263:00 pmRNSLoan Conversion
24th Feb 20267:00 amRNSTVL Appoints Wates group
12th Feb 20267:00 amRNSTVL Advances On-Site Lithium Recovery
5th Feb 20263:26 pmRNSGrant of Share Awards
3rd Feb 20267:00 amRNSTVL FEED Study
29th Jan 20264:07 pmRNSLoan Conversion
28th Jan 20269:35 amRNSTVL and Glencore Sign Binding Offtake Agreement
14th Jan 20267:00 amRNSTVL FEED Study Update
9th Dec 202511:40 amRNSLoan Conversion
27th Nov 20253:00 pmRNSExercise of Warrants and Loan Conversion
10th Nov 20257:00 amRNSTees Valley Lithium Financing and Project Delivery
5th Nov 20257:00 amRNSAppointment of ABG Sundal Collier ASA
3rd Nov 20251:28 pmRNSExercise of Warrants
29th Oct 20254:23 pmRNSExercise of Warrants
15th Oct 20257:00 amRNSInterim Results
9th Oct 20257:00 amRNSTVL: Appointment of COO & Launch of OEP
6th Oct 20257:00 amRNSTVL: Lower CAPEX, Higher Uptime, Stronger Outlook
29th Aug 20257:00 amRNSTVL Project and Leadership Update
31st Jul 20253:00 pmRNSExercise of Warrants
31st Jul 20257:00 amRNSFEED Funding and Equity Funding Proposal
17th Jul 20257:00 amRNSTVL Secures Binding Feedstock Agreement
25th Jun 20257:00 amRNSOversubscribed Subscription to raise £500,000
18th Jun 20251:00 pmRNSResult of AGM
2nd Jun 20257:05 amRNSAlkemy Shareholder Call
2nd Jun 20257:00 amRNSTVL Update: Process Validated, CAPEX Confirmed
23rd May 20253:00 pmRNSNotice of AGM
21st May 20254:30 pmRNSFinal Results
12th May 20257:05 amRNS-RAlkemy Shareholder Call
12th May 20257:00 amRNSExclusivity Agreement Signed with Ara Partners
18th Mar 20257:00 amRNSTVL - Exclusive Negotiation for Lithium Supply
18th Feb 20257:00 amRNSTVL Appoints New CEO and Commences FEED Study
17th Feb 20258:27 amRNSReplacement: Subscription to raise £0.75 million
17th Feb 20257:00 amRNSPlacing to raise £1.035 million
31st Jan 20257:00 amRNSTVL Collaborates with Veolia
6th Nov 20247:00 amRNSChairman Share Purchases
24th Oct 20248:00 amRNSABG Sundal Collier to lead US$25m Convertible Bond
2nd Oct 20247:00 amRNSInterim Results
5th Aug 20247:00 amRNSCorporate Update
2nd Jul 20242:00 pmRNSResult of AGM
5th Jun 20244:30 pmRNSNotice of AGM
30th May 20244:30 pmRNSAnnual Report & Financial Statements
26th Feb 20247:00 amRNSChange of Adviser
30th Jan 20247:00 amRNSMOU with Syrah for UK’s first Graphite refinery
18th Jan 20247:00 amRNSCorporate Update
18th Dec 20237:00 amRNSOversubscribed Placing to raise £650,000
4th Dec 20237:00 amRNSTVL Secures Technology and Vendor Partnerships
20th Nov 20237:00 amRNSAppointment of Battery Metals Supply Chain Expert

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.